-
1
-
-
77950263954
-
Prevalence of diabetes among men and women in China
-
China National Diabetes and Metabolic Disorders Study Group, doi:10.1056/NEJMoa0908292 PubMed
-
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101. doi:10.1056/NEJMoa0908292 PubMed
-
(2010)
N Engl J Med.
, vol.362
, pp. 1090-1101
-
-
Yang, W.1
Lu, J.2
Weng, J.3
Jia, W.4
Ji, L.5
Xiao, J.6
Shan, Z.7
Liu, J.8
Tian, H.9
Ji, Q.10
Zhu, D.11
Ge, J.12
Lin, L.13
Chen, L.14
Guo, X.15
Zhao, Z.16
Li, Q.17
Zhou, Z.18
Shan, G.19
He, J.20
more..
-
2
-
-
79960100991
-
-
Feb 8. doi. 10.1111/j.1365-2362.2011.02479.x
-
Hsieh MC, Hsieh YT, Cho TJ, Chen JF, Lin SD, Chen HC et al. Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control. 2011 Feb 8. doi. 10.1111/j.1365-2362.2011.02479.x
-
(2011)
Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control
-
-
Hsieh, M.C.1
Hsieh, Y.T.2
Cho, T.J.3
Chen, J.F.4
Lin, S.D.5
Chen, H.C.6
-
3
-
-
34250799639
-
Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats
-
doi:10.1159/000101471 PubMed
-
Yi F, dos Santos EA, Xia M, Chen QZ, Li PL, Li N. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol. 2007; 27: 262-268. doi:10.1159/000101471 PubMed
-
(2007)
Am J Nephrol.
, vol.27
, pp. 262-268
-
-
Yi, F.1
dos Santos, E.A.2
Xia, M.3
Chen, Q.Z.4
Li, P.L.5
Li, N.6
-
4
-
-
3242797419
-
Activation of mesangial cell MAPK in response to homocysteine
-
doi:10.1111/j.1523-1755.2004.00795.x PubMed
-
Ingram AJ, Krepinsky JC, James L, Austin RC, Tang D, Salapatek AM, Thai K, Scholey JW. Activation of mesangial cell MAPK in response to homocysteine. Kidney Int. 2004; 66: 733-745. doi:10.1111/j.1523-1755.2004.00795.x PubMed
-
(2004)
Kidney Int.
, vol.66
, pp. 733-745
-
-
Ingram, A.J.1
Krepinsky, J.C.2
James, L.3
Austin, R.C.4
Tang, D.5
Salapatek, A.M.6
Thai, K.7
Scholey, J.W.8
-
5
-
-
33745711919
-
Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats
-
doi:10.1038/sj.ki.5001517 PubMed
-
Yi F, Zhang AY, Li N, Muh RW, Fillet M, Renert AF, Li PL. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006; 70: 88-96. doi:10.1038/sj.ki.5001517 PubMed
-
(2006)
Kidney Int.
, vol.70
, pp. 88-96
-
-
Yi, F.1
Zhang, A.Y.2
Li, N.3
Muh, R.W.4
Fillet, M.5
Renert, A.F.6
Li, P.L.7
-
6
-
-
38349181044
-
Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation
-
doi:10.1152/ajprenal.00331.2007 PubMed
-
Hwang SY, Woo CW, Au-Yeung KK, Siow YL, Zhu TY, O K. Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation. Am J Physiol Renal Physiol. 2008; 294: F236-F244. doi:10.1152/ajprenal.00331.2007 PubMed
-
(2008)
Am J Physiol Renal Physiol
, vol.294
-
-
Hwang, S.Y.1
Woo, C.W.2
Au-Yeung, K.K.3
Siow, Y.L.4
Zhu, T.Y.5
O, K.6
-
7
-
-
0035116352
-
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort
-
Pubmed
-
Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001; 73: 613-621. PubMed
-
(2001)
Am J Clin Nutr.
, vol.73
, pp. 613-621
-
-
Jacques, P.F.1
Bostom, A.G.2
Wilson, P.W.3
Rich, S.4
Rosenberg, I.H.5
Selhub, J.6
-
8
-
-
0031841522
-
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
-
doi:10.1007/s001250050969 PubMed
-
Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 1998; 41: 684-693. doi:10.1007/s001250050969 PubMed
-
(1998)
Diabetologia
, vol.41
, pp. 684-693
-
-
Chico, A.1
Pérez, A.2
Córdoba, A.3
Arcelús, R.4
Carreras, G.5
de Leiva, A.6
González-Sastre, F.7
Blanco-Vaca, F.8
-
9
-
-
0016722112
-
Labile methyl balances for normal humans on various dietary regimens
-
doi:10.1016/0026-0495(75)90040-2 PubMed
-
Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism. 1975; 24: 721-735. doi:10.1016/0026-0495(75)90040-2 PubMed
-
(1975)
Metabolism.
, vol.24
, pp. 721-735
-
-
Mudd, S.H.1
Poole, J.R.2
-
10
-
-
33846593344
-
The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women
-
doi:10.1016/j.bone.2006.10.008 PubMed
-
Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W, West C, Fraser WD, Ranganath LR. The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone. 2007; 40: 730-736. doi:10.1016/j.bone.2006.10.008 PubMed
-
(2007)
Bone.
, vol.40
, pp. 730-736
-
-
Baines, M.1
Kredan, M.B.2
Usher, J.3
Davison, A.4
Higgins, G.5
Taylor, W.6
West, C.7
Fraser, W.D.8
Ranganath, L.R.9
-
11
-
-
60249097214
-
Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004
-
doi:10.3945/jn.108.092726 PubMed
-
Ganji V, Kafai MR. Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nutr. 2009; 139: 345-352. doi:10.3945/jn.108.092726 PubMed
-
(2009)
J Nutr.
, vol.139
, pp. 345-352
-
-
Ganji, V.1
Kafai, M.R.2
-
12
-
-
0037898378
-
Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes
-
doi:10.1007/s00125-003-1104-x PubMed
-
Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KM, Knowler WC, Hanson RL. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia. 2003; 46: 766-772. doi:10.1007/s00125-003-1104-x PubMed
-
(2003)
Diabetologia.
, vol.46
, pp. 766-772
-
-
Looker, H.C.1
Fagot-Campagna, A.2
Gunter, E.W.3
Pfeiffer, C.M.4
Narayan, K.M.5
Knowler, W.C.6
Hanson, R.L.7
-
13
-
-
0037229387
-
Prevalence and progression of peripheral arterial calcifications in patients with ESRD
-
doi:10.1053/ajkd.2003.50033 PubMed
-
Kronenberg F, Mündle M, Längle M, Neyer U. Prevalence and progression of peripheral arterial calcifications in patients with ESRD. Am J Kidney Dis. 2003; 41: 140-148. doi:10.1053/ajkd.2003.50033 PubMed
-
(2003)
Am J Kidney Dis.
, vol.41
, pp. 140-148
-
-
Kronenberg, F.1
Mündle, M.2
Längle, M.3
Neyer, U.4
-
14
-
-
0033647409
-
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance
-
doi:10.2337/diacare.23.12.1816 PubMed
-
Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000; 23: 1816-1822. doi:10.2337/diacare.23.12.1816 PubMed
-
(2000)
Diabetes Care.
, vol.23
, pp. 1816-1822
-
-
Buysschaert, M.1
Dramais, A.S.2
Wallemacq, P.E.3
Hermans, M.P.4
-
15
-
-
0036518145
-
Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease
-
doi:10.2337/diacare.25.3.632 PubMed
-
González-Clemente JM, Deulofeu R, Mitjavila J, Galdon G, Ortega E, Caixàs A, Giménez-Pérez G, Mauricio D. Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease. Diabetes Care. 2002; 25: 632-633. doi:10.2337/diacare.25.3.632 PubMed
-
(2002)
Diabetes Care.
, vol.25
, pp. 632-633
-
-
González-Clemente, J.M.1
Deulofeu, R.2
Mitjavila, J.3
Galdon, G.4
Ortega, E.5
Caixàs, A.6
Giménez-Pérez, G.7
Mauricio, D.8
-
16
-
-
0035165562
-
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study
-
doi:10.1161/01.ATV.21.1.74 PubMed
-
Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001; 21: 74-81. doi:10.1161/01.ATV.21.1.74 PubMed
-
(2001)
Arterioscler Thromb Vasc Biol.
, vol.21
, pp. 74-81
-
-
Jager, A.1
Kostense, P.J.2
Nijpels, G.3
Dekker, J.M.4
Heine, R.J.5
Bouter, L.M.6
Donker, A.J.7
Stehouwer, C.D.8
-
18
-
-
0028867689
-
Prevention of diabetic renal disease with special reference to microalbuminuria
-
doi:10.1016/S0140-6736(95)91747-0 PubMed
-
Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995; 346: 1080-1084. doi:10.1016/S0140-6736(95)91747-0 PubMed
-
(1995)
Lancet.
, vol.346
, pp. 1080-1084
-
-
Mogensen, C.E.1
Keane, W.F.2
Bennett, P.H.3
Jerums, G.4
Parving, H.H.5
Passa, P.6
Steffes, M.W.7
Striker, G.E.8
Viberti, G.C.9
-
19
-
-
33645861392
-
-
Summary of revisions for the 2006 Clinical Practice Recommendations., PubMed
-
Summary of revisions for the 2006 Clinical Practice Recommendations. Diabetes Care. 2006; 29 (Suppl 1): S3. PubMed
-
(2006)
Diabetes Care
, vol.29
, Issue.SUPPL. 1
-
-
-
20
-
-
77950509384
-
-
Summary of revisions for the 2010 Clinical Practice Recommendations, doi:10.2337/dc10-S003 PubMed
-
Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care. 2010; 33 (Suppl 1): S3. doi:10.2337/dc10-S003 PubMed
-
(2010)
Diabetes Care.
, vol.33
, Issue.SUPPL. 1
-
-
-
21
-
-
84855679815
-
Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes
-
doi:10.4093/kdj.2010.34.3.200 PubMed
-
Cho EH, Kim EH, Kim WG, Jeong EH, Koh EH, Lee WJ, Kim MS, Park JY, Lee KU. Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes. Korean Diabetes J. 2010; 34: 200-206. doi:10.4093/kdj.2010.34.3.200 PubMed
-
(2010)
Korean Diabetes J.
, vol.34
, pp. 200-206
-
-
Cho, E.H.1
Kim, E.H.2
Kim, W.G.3
Jeong, E.H.4
Koh, E.H.5
Lee, W.J.6
Kim, M.S.7
Park, J.Y.8
Lee, K.U.9
-
22
-
-
9144225352
-
Facts and recommendations about total homocysteine determinations: an expert opinion
-
doi:10.1373/clinchem.2003.021634 PubMed
-
Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004; 50: 1482-1483. doi:10.1373/clinchem.2003.021634 PubMed
-
(2004)
Clin Chem.
, vol.50
, pp. 1482-1483
-
-
Refsum, H.1
Smith, A.D.2
Ueland, P.M.3
Nexo, E.4
Clarke, R.5
McPartlin, J.6
-
23
-
-
34247846068
-
Vitamin B-12 deficiency is prevalent in 35-to 64-year-old Chinese adults
-
Pubmed
-
Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, Li Z. Vitamin B-12 deficiency is prevalent in 35-to 64-year-old Chinese adults. J Nutr. 2007; 137: 1278-1285. PubMed
-
(2007)
J Nutr.
, vol.137
, pp. 1278-1285
-
-
Hao, L.1
Ma, J.2
Zhu, J.3
Stampfer, M.J.4
Tian, Y.5
Willett, W.C.6
Li, Z.7
-
24
-
-
53749096863
-
10-year follow-up of intensive glucose control in type 2 diabetes
-
doi:10.1056/NEJMoa0806470 PubMed
-
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-1589. doi:10.1056/NEJMoa0806470 PubMed
-
(2008)
N Engl J Med.
, vol.359
, pp. 1577-1589
-
-
Holman, R.R.1
Paul, S.K.2
Bethel, M.A.3
Matthews, D.R.4
Neil, H.A.5
-
25
-
-
79952156788
-
The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats
-
doi:10.1002/dmrr.1172 PubMed
-
Levin-Iaina N, Iaina A, Raz I. The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats. Diabetes Metab Res Rev. 2011; 27: 235-243. doi:10.1002/dmrr.1172 PubMed
-
(2011)
Diabetes Metab Res Rev.
, vol.27
, pp. 235-243
-
-
Levin-Iaina, N.1
Iaina, A.2
Raz, I.3
-
26
-
-
77953263473
-
Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats
-
Pubmed
-
Li X, Cui X, Sun X, Li X, Zhu Q, Li W. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res. 2010; 24: 893-899. PubMed
-
(2010)
Phytother Res.
, vol.24
, pp. 893-899
-
-
Li, X.1
Cui, X.2
Sun, X.3
Li, X.4
Zhu, Q.5
Li, W.6
-
27
-
-
42549150244
-
Genetic polymorphism of MTHFR G1793A in Chinese populations
-
doi:10.1007/s10654-008-9243-5 PubMed
-
Mao R, Fan Y, Chen F, Fu S. Genetic polymorphism of MTHFR G1793A in Chinese populations. Eur J Epidemiol. 2008; 23: 363-368. doi:10.1007/s10654-008-9243-5 PubMed
-
(2008)
Eur J Epidemiol.
, vol.23
, pp. 363-368
-
-
Mao, R.1
Fan, Y.2
Chen, F.3
Fu, S.4
-
28
-
-
33845200050
-
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients
-
doi:10.1016/j.diabres.2006.05.018 PubMed
-
Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2007; 75: 99-106. doi:10.1016/j.diabres.2006.05.018 PubMed
-
(2007)
Diabetes Res Clin Pract.
, vol.75
, pp. 99-106
-
-
Mtiraoui, N.1
Ezzidi, I.2
Chaieb, M.3
Marmouche, H.4
Aouni, Z.5
Chaieb, A.6
Mahjoub, T.7
Vaxillaire, M.8
Almawi, W.Y.9
-
29
-
-
2942551890
-
Management of hyperhomocysteinemia
-
doi:10.1089/154041903322294489 PubMed
-
Chan E, Fonseca VA. Management of hyperhomocysteinemia. Metab Syndr Relat Disord. 2003; 1: 159-170. doi:10.1089/154041903322294489 PubMed
-
(2003)
Metab Syndr Relat Disord.
, vol.1
, pp. 159-170
-
-
Chan, E.1
Fonseca, V.A.2
-
30
-
-
77951645401
-
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
-
doi:10.1001/jama.2010.490 PubMed
-
House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, Dresser GK, Spence JD. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010; 303: 1603-1609. doi:10.1001/jama.2010.490 PubMed
-
(2010)
JAMA.
, vol.303
, pp. 1603-1609
-
-
House, A.A.1
Eliasziw, M.2
Cattran, D.C.3
Churchill, D.N.4
Oliver, M.J.5
Fine, A.6
Dresser, G.K.7
Spence, J.D.8
-
31
-
-
77951138812
-
The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels
-
doi:10.1179/147 683010X12611460763607 PubMed
-
Jian-bo L, Cheng-ya W, Jia-wei C, Xiao-lu L, Zhen-qing F, Hong-tai M. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels. Nutr Neurosci. 2010; 13: 79-86. doi:10.1179/147 683010X12611460763607 PubMed
-
(2010)
Nutr Neurosci.
, vol.13
, pp. 79-86
-
-
Jian-bo, L.1
Cheng-ya, W.2
Jia-wei, C.3
Xiao-lu, L.4
Zhen-qing, F.5
Hong-tai, M.6
-
32
-
-
21544470960
-
Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials
-
Pubmed
-
Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan. 2005; 14: 48-54. PubMed
-
(2005)
Acta Neurol Taiwan.
, vol.14
, pp. 48-54
-
-
Sun, Y.1
Lai, M.S.2
Lu, C.J.3
|